Paragon Care Opens Two Share-Market Capital Tools
Paragon Care has lined up an on-market buy-back of up to 82.8 million shares, worth about $10.8 million at the latest closing price, while its employee trust can acquire a further 23.9 million shares. The transactions give the healthcare group two sizeable tools for managing its capital and incentive plans, although neither maximum is guaranteed to be completed.
- Buy-back of up to 82.8 million shares
- Estimated maximum cash cost of $10.76 million
- Represents approximately 5% of current shares on issue
- Employee trust authorised to buy up to 23.9 million shares
- Buy-back timing depends on FY26 results and market conditions
Paragon Care Sets 82.8 Million Share Buy-Back
Paragon Care Limited (ASX:PGC) has announced an on-market buy-back of up to 82,765,269 ordinary shares, a programme equivalent to approximately 5% of its current shares on issue. At the company’s closing price of $0.13 on 15 September, completing the buy-back in full would require about $10.76 million.
The scale is significant enough to matter to the share count, but the announcement does not commit Paragon Care to buying the full amount. The company says purchases will depend on market conditions, trading volumes and other relevant factors, and it can suspend or terminate the programme at any time.
Employee Trust Can Acquire 23.9 Million Shares
Alongside the buy-back, Paragon Care has instructed Pacific Custodians, acting as trustee for the Paragon Care Employee Share Trust, to acquire up to 23,900,401 shares on market. Those shares are intended to support future vesting and grants under the company’s Employee Incentive Plan.
The trust’s purchases will be capped at no more than 5% above the volume-weighted average share price over the five trading days before each purchase. The company says the transactions will comply with the Corporations Act and its Securities Trading Policy, with ASX notices to be issued when the trust stops buying and when the purchase is completed.
Buy-Back Timing Tied to FY26 Results
Paragon Care intends to begin the buy-back on or shortly after releasing its FY26 results. The company has framed the programme as a capital-management decision rather than an unconditional commitment to deploy the full $10.76 million, leaving the eventual number of shares acquired and cash spent open.
For shareholders, the two transactions create a tension worth tracking: the buy-back can reduce shares on issue if completed, while the employee trust’s purchases are designed to provide shares for future incentive awards. The filing does not state how the company expects the transactions to interact, nor does it provide a forecast for the eventual effect on the share count.
Bottom Line?
The headline figure is the potential $10.76 million deployment, but the more useful signal will be how much Paragon Care actually spends once FY26 results and market conditions determine the pace of buying.
Questions in the middle?
- How many shares will Paragon Care ultimately repurchase, and at what average price?
- Will the employee trust acquire the full 23.9 million shares for future incentive awards?
- What will the combined transactions mean for shares on issue and cash available after FY26 results?
